-
公开(公告)号:US20250009659A1
公开(公告)日:2025-01-09
申请号:US18709728
申请日:2022-11-10
Applicant: UNIVERSITE DE RENNES , Centre National de la Recherche Scientifique , École Nationale Supérieure de Chimie de Rennes , Institut National des Sciences Appliquées de Rennes , Norwegian University of Science and Technology
Inventor: Thierry BENVEGNU , Thomas VIVES , Matthieu HICGUET , Sébastien SIMON , Johan SJÖBLOM
IPC: A61K9/127 , C07C69/608 , C07C219/10 , C07D249/04 , C08G65/00
Abstract: The present invention thus provides a novel family of liposomal compositions (nanocarriers), hereinafter referred to as Tetra-Acidosomes, comprising natural tetrameric acid (TA) lipids and/or novel chemically functionalized tetrameric acid (CFTA) lipids, for drug delivery applications.
-
公开(公告)号:US11820745B2
公开(公告)日:2023-11-21
申请号:US17858204
申请日:2022-07-06
Applicant: Synaptogenix, Inc.
Inventor: Thomas J. Nelson , Daniel L. Alkon
IPC: C07D303/42 , A61K31/045 , A61K31/23 , A61K31/231 , A61K31/335 , A61P25/00 , A61P25/28 , A61K31/201 , C07C31/13 , C07C31/133 , C07C53/134 , C07C69/608 , C07D303/40 , C12N9/12
CPC classification number: C07D303/42 , A61K31/045 , A61K31/201 , A61K31/23 , A61K31/231 , A61K31/335 , A61P25/00 , A61P25/28 , C07C31/13 , C07C31/1333 , C07C53/134 , C07C69/608 , C07D303/40 , C12N9/12 , C12Y207/11013
Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.
-
公开(公告)号:US20220356161A1
公开(公告)日:2022-11-10
申请号:US17858204
申请日:2022-07-06
Applicant: Synaptogenix, Inc.
Inventor: Thomas J. NELSON , Daniel L. ALKON
IPC: C07D303/42 , A61K31/045 , A61K31/23 , A61K31/231 , A61K31/335 , A61P25/00 , A61P25/28 , A61K31/201 , C07C31/13 , C07C31/133 , C07C53/134 , C07C69/608 , C07D303/40 , C12N9/12
Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.
-
公开(公告)号:US20210130281A1
公开(公告)日:2021-05-06
申请号:US17149170
申请日:2021-01-14
Applicant: XWPHARMA LTD.
Inventor: JIA-NING XIANG , XUESONG XU , XUAN ZHANG
IPC: C07C69/78 , C07C255/57 , C07D213/79 , C07D213/80 , C07D309/12 , C07C271/22 , C07C271/34 , C07C69/612 , C07D317/64 , C07D333/38 , C07C229/08 , C07C233/47 , C07D207/16 , C07D307/68 , C07B59/00 , C07C69/76 , C07C69/24 , C07C229/36 , C07C69/608 , C07C317/44 , C07D277/56 , C07D211/46 , C07C69/738 , C07C69/28 , C07C69/22 , C07C69/34 , C07C69/618 , C07C69/74 , C07C69/96 , C07C229/34 , C07C317/14 , C07D207/12 , C07D211/44 , C07D277/30
Abstract: Provided are prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
-
公开(公告)号:US20200369598A1
公开(公告)日:2020-11-26
申请号:US16988027
申请日:2020-08-07
Applicant: XW LABORATORIES INC.
Inventor: JIA-NING XIANG , XUESONG XU , XUAN ZHANG
IPC: C07C69/78 , C07C255/57 , C07D213/79 , C07D213/80 , C07D309/12 , C07C271/22 , C07C271/34 , C07C69/612 , C07D317/64 , C07D333/38 , C07C229/08 , C07C233/47 , C07D207/16 , C07D307/68 , C07B59/00 , C07C69/76 , C07C69/24 , C07C229/36 , C07C69/608 , C07C317/44 , C07D277/56 , C07D211/46 , C07C69/738 , C07C69/28 , C07C69/22 , C07C69/34 , C07C69/618 , C07C69/74 , C07C69/96 , C07C229/34 , C07C317/14 , C07D207/12 , C07D211/44 , C07D277/30
Abstract: Provided are prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
-
公开(公告)号:US20200010406A1
公开(公告)日:2020-01-09
申请号:US16090572
申请日:2017-04-18
Applicant: GENTEC, S.A.
IPC: C07C231/14 , C07C67/04 , C07C69/608 , C07C233/10
Abstract: It is provided a process for the preparation of bimatoprost, which comprises: a) reacting a compound of formula (III) with ethylamine in the presence of a suitable solvent; and b) deprotecting compound obtained in step a) to obtain bimatoprost, wherein R1 is selected from (C1-C16)alkyl, (C1C16)haloalkyl, (C2-C16)alkenyl, (C2-C16)haloalkenyl, (C1-C16)alkoxy(C1-C16)alkyl, aryl, (C1-C16)alkylaryl, allyl, —(CH2—CH2—O)n—CH3 wherein n=1, 2, 3 or 4, and —CH(O—CH2—CH2)2; R2 is selected from H, (C1-C16)alkyl, (C1-C16)haloalkyl, (C2-C16)alkenyl, (C2-C16)haloalkenyl, (C1-C16)alkoxy(CrC16)alkyl, aryl, (C1-C16)alkylaryl, allyl; or, alternatively, R1 and R2 taken together are selected from —CH2—CH2—CH2—, —CH2—CH2—, —O—CH2—CH2—, and —O—CH═CH—. There are also provided intermediates useful in such preparation process.
-
公开(公告)号:US10221122B2
公开(公告)日:2019-03-05
申请号:US15573291
申请日:2016-05-12
Applicant: Council of Scientific & Industrial Research
Inventor: Dumbala Srinivasa Reddy , Remya Ramesh
IPC: C07C67/08 , C07C29/147 , C07C67/03 , C07C67/31 , C07C67/317 , C07D307/935 , C07C33/12 , C07C69/608 , C07C69/732 , C07C69/738 , A01N31/04 , A01N37/06
Abstract: The present invention relates to an enantiospecific process for the preparation of (R) and (S) enantiomers of sex pheromones of the long-tailed mealybug with high enantiopurity.
-
公开(公告)号:US20180346412A1
公开(公告)日:2018-12-06
申请号:US15779982
申请日:2016-12-08
Applicant: Givaudan, S.A.
Inventor: Corinne BAUMGARTNER
IPC: C07C255/31 , C07C69/608 , C11B9/00
CPC classification number: C07C69/608 , C07C255/31 , C07C2601/08 , C07C2601/14 , C07C2602/50 , C11B9/003 , C11B9/0034
Abstract: The present invention refers to substituted cyclopentyl- and cyclohexyl-derivatives of formula (I) wherein n, R1, R2, R3, R4 and X have the same meaning as given in the description. The invention further refers to fragrance compositions and fragranced articles comprising them.
-
公开(公告)号:US20180186735A1
公开(公告)日:2018-07-05
申请号:US15895685
申请日:2018-02-13
Applicant: Dermira, Inc.
Inventor: Anthony Adrian Shaw , Enrico Vigano , Renato Molteni
IPC: C07D207/12 , C07C63/24 , C07C67/08 , C07C69/608 , C07F11/00 , B01D9/00
CPC classification number: C07D207/12 , B01D9/00 , C07C63/24 , C07C67/08 , C07C69/608 , C07C201/12 , C07C303/22 , C07C309/30 , C07C309/73 , C07F11/005 , C07C205/57
Abstract: Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.
-
公开(公告)号:US09932286B2
公开(公告)日:2018-04-03
申请号:US14983330
申请日:2015-12-29
Applicant: BioElectron Technology Corporation
Inventor: Guy M. Miller , Sidney M. Hecht , Orion D. Jankowski , Kieron E. Wesson , Paul Mollard
IPC: C07C50/38 , C07C50/04 , A61K31/05 , A61K31/355 , C07C39/08 , C07C39/11 , C07C39/19 , C07C39/24 , C07C50/02 , C07C50/06 , C07C50/24 , C07C50/28 , C07C215/56 , C07C403/04 , C07C403/08 , C07C403/18 , C07C43/225 , C07C43/23 , C07C47/277 , C07C69/608 , C07C69/618 , C07C233/27 , C07C233/32 , C07C255/37
CPC classification number: C07C50/04 , A61K31/05 , A61K31/355 , C07C39/08 , C07C39/11 , C07C39/19 , C07C39/245 , C07C43/225 , C07C43/23 , C07C47/277 , C07C50/02 , C07C50/06 , C07C50/24 , C07C50/28 , C07C69/608 , C07C69/618 , C07C215/56 , C07C233/27 , C07C233/32 , C07C255/37 , C07C403/04 , C07C403/08 , C07C403/18 , C07C2601/16
Abstract: Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed, as well as compounds useful in the methods of the invention. Methods and compounds useful in treating other disorders are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed.
-
-
-
-
-
-
-
-
-